| Omar Said Nehme, MD | |
|
1725 W Harrison St Ste 207, Chicago, IL 60612-3988 | |
| (312) 942-5861 | |
| (260) 918-2137 |
| Full Name | Omar Said Nehme |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 28 Years |
| Location | 1725 W Harrison St Ste 207, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225013972 | NPI | - | NPPES |
| 9115389 | Other | IL | ANTHEM BC/BS |
| P00325762 | Other | IN | RAILROAD MEDICARE |
| 000000381391 | Other | IN | ANTHEM BC/BS |
| 01049531A | Other | IN | STATE LICENSE |
| 01049531B | Other | IN | CSR |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush University Medical Center | Chicago, IL | Hospital |
| Rush Oak Park Hospital | Oak park, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush University Medical Center | 5496658874 | 1007 |
News Archive
The autoimmune disease lupus, which can cause fatigue, a facial rash, and joint pain, strikes females far more often than males. Eight-five percent of people with lupus are female, and their second X chromosome seems partly to blame.
Many patients with rare, fast-growing neuroendocrine tumors respond well to a common immunotherapy drug combination, according to the first peer-reviewed publication out of DART, short for Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors, a unique rare cancer clinical trial.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer and Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe, signed a collaboration agreement to commercialize Colox, a minimally invasive colorectal cancer assay within the Unilabs network. The test will be available initially in the Swiss and Swedish markets.
› Verified 6 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
The autoimmune disease lupus, which can cause fatigue, a facial rash, and joint pain, strikes females far more often than males. Eight-five percent of people with lupus are female, and their second X chromosome seems partly to blame.
Many patients with rare, fast-growing neuroendocrine tumors respond well to a common immunotherapy drug combination, according to the first peer-reviewed publication out of DART, short for Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors, a unique rare cancer clinical trial.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer and Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe, signed a collaboration agreement to commercialize Colox, a minimally invasive colorectal cancer assay within the Unilabs network. The test will be available initially in the Swiss and Swedish markets.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Omar Said Nehme, MD 1725 W Harrison St Ste 207, Chicago, IL 60612-3988 Ph: (312) 942-5861 | Omar Said Nehme, MD 1725 W Harrison St Ste 207, Chicago, IL 60612-3988 Ph: (312) 942-5861 |
News Archive
The autoimmune disease lupus, which can cause fatigue, a facial rash, and joint pain, strikes females far more often than males. Eight-five percent of people with lupus are female, and their second X chromosome seems partly to blame.
Many patients with rare, fast-growing neuroendocrine tumors respond well to a common immunotherapy drug combination, according to the first peer-reviewed publication out of DART, short for Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors, a unique rare cancer clinical trial.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
Diagnoplex SA, a developer of molecular diagnostics for colorectal cancer and Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe, signed a collaboration agreement to commercialize Colox, a minimally invasive colorectal cancer assay within the Unilabs network. The test will be available initially in the Swiss and Swedish markets.
› Verified 6 days ago
Dr. Sorin C Danciu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |